The Patent Finder

Askbio Inc.

21 patents currently held · Updated Nov 21, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Previously recorded as Asklepios Biopharmaceutical, Inc. (to 2025)

4
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 20, 2027
    The maintenance fee for Modified Soluble VEGF RECEPTOR-1 Genes and Vectors for Gene Therapy (US 10,385,112) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Method for the Construction of Specific Promoters (US 10,508,275) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,632,765Modified factor VIII and factor IX genes and vectors for gene therapy
In force
 · USPTO record
In forceUSPTO record
US 9,506,052Modified factor VIII and factor IX genes
In force (reinstated)
 · USPTO record
In force (reinstated)USPTO record
US 8,198,421Modified factor VIII and factor IX genes and vectors for gene therapy
In force
 · USPTO record
In forceUSPTO record
US 10,065,021Convection-enhanced delivery catheter with removable stiffening member and method for using same
In force
 · USPTO record
In forceUSPTO record
US 10,385,112Modified Soluble VEGF RECEPTOR-1 Genes and Vectors for Gene Therapy
In force
 · High confidence
In forceHigh confidence
US 11,414,678Modified Soluble VEGF RECEPTOR-1 Genes and Vectors for Gene Therapy
In force
 · High confidence
In forceHigh confidence
US 10,508,275Method for the Construction of Specific Promoters
In force
 · High confidence
In forceHigh confidence
US 11,492,618Expression Control Using a Regulatable Intron
In force
 · High confidence
In forceHigh confidence
US 12,600,969Expression Control Using a Regulatable Intron
In force
 · High confidence
In forceHigh confidence
US 11,235,070Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes
In force (reinstated)
 · Medium confidence
In force (reinstated)Medium confidence
10 of 21 patents shown.
Pro members see all 21.
Pro members: see all 21 patents
Also on record, not counted in the 21: 1 patent in force now held by others · 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 no status recorded

Showing 1 to 2 of 2, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.

ApplicationFiledStatus
18/864,134Jun 22, 2023No status recorded
18/857,723Apr 20, 2023No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited